TD Private Client Wealth’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-18
Closed -$243 1519
2025
Q1
$243 Buy
+18
New +$243 ﹤0.01% 1373